Loading viewer...
investor_presentation
Format: PDF investor_presentation
Rocket Pharmaceuticals presents its gene therapy pipeline and clinical development strategy across multiple rare genetic disorders including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, Infantile Malignant Osteopetrosis, and Danon Disease. The presentation outlines the company's mission centered on trust, generosity, and curiosity in advancing innovative genetic treatments for patients and families.
investor_presentation
44 Pages
investor_presentation
20 Pages
Amadeus IT Group